308 related articles for article (PubMed ID: 35458497)
1. Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study.
Akinosoglou K; Savopoulos C; Pouliakis A; Triantafyllidis C; Markatis E; Golemi F; Liontos A; Vadala C; Papanikolaou IC; Dimakopoulou V; Xarras P; Varela K; Kaiafa G; Mitsianis A; Chatzistamati A; Randou E; Savvanis S; Pavlaki M; Efraimidis G; Samaras V; Papazoglou D; Konstantinidou A; Panagopoulos P; Milionis H; On Behalf Of The Interact Study Group
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458497
[TBL] [Abstract][Full Text] [Related]
2. Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort study.
Xynogalos S; Simeonidis D; Papageorgiou G; Pouliakis A; Charalambakis N; Lianos E; Mazlimoglou E; Liatsos AN; Kosmas C; Ziras N
Support Care Cancer; 2022 Aug; 30(8):6973-6984. PubMed ID: 35552827
[TBL] [Abstract][Full Text] [Related]
3. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
Jonmarker S; Hollenberg J; Dahlberg M; Stackelberg O; Litorell J; Everhov ÅH; Järnbert-Pettersson H; Söderberg M; Grip J; Schandl A; Günther M; Cronhjort M
Crit Care; 2020 Nov; 24(1):653. PubMed ID: 33225952
[TBL] [Abstract][Full Text] [Related]
4. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
5. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
6. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
Bikdeli B; Talasaz AH; Rashidi F; Bakhshandeh H; Rafiee F; Rezaeifar P; Baghizadeh E; Matin S; Jamalkhani S; Tahamtan O; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Khalili H; Yadollahzadeh M; Riahi T; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Amin A; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Dobesh PP; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Sadeghipour P
Thromb Haemost; 2022 Jan; 122(1):131-141. PubMed ID: 33865239
[TBL] [Abstract][Full Text] [Related]
7. Weight-adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery.
Tseng EK; Kolesar E; Handa P; Douketis JD; Anvari M; Tiboni M; Crowther MA; Siegal DM
J Thromb Haemost; 2018 Oct; 16(10):2008-2015. PubMed ID: 30099852
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
[TBL] [Abstract][Full Text] [Related]
9. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
[TBL] [Abstract][Full Text] [Related]
10. Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin.
Karathanos C; Kakkos SK; Georgiadis G; Ioannou C; Vasdekis S; Chatzis D; Latzios P; Giannoukas AD;
Phlebology; 2023 Apr; 38(3):141-149. PubMed ID: 36461172
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.
Bellmunt-Montoya S; Riera C; Gil D; Rodríguez M; García-Reyes M; Martínez-Carnovale L; Marrero C; Gil M; Ruiz-Rodríguez JC; Ferrer R; de Nadal M; Monreal M; Llagostera S
Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):628-634. PubMed ID: 33583710
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals.
Parks AL; Auerbach AD; Schnipper JL; Bertram A; Jeon SY; Boyle B; Fang MC; Gadrey SM; Siddiqui ZK; Brotman DJ;
PLoS One; 2022; 17(5):e0266944. PubMed ID: 35511940
[TBL] [Abstract][Full Text] [Related]
13. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
Hyers TM; Spyropoulos AC;
J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
[TBL] [Abstract][Full Text] [Related]
14. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
Ahmed HY; Papali A; Haile T; Shrestha GS; Schultz MJ; Lundeg G; Akrami KM;
Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):99-109. PubMed ID: 33432908
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units.
Lavinio A; Ercole A; Battaglini D; Magnoni S; Badenes R; Taccone FS; Helbok R; Thomas W; Pelosi P; Robba C;
Crit Care; 2021 Apr; 25(1):155. PubMed ID: 33888132
[TBL] [Abstract][Full Text] [Related]
16. Venous Thromboembolism in Hospitalized COVID-19 Patients Treated in a Single Academic Center in Mexico: A Case Series Study.
Ontiveros N; Becerril-Gaitan A; Llausas-Villarreal A; Gonzalez-Urquijo M; Paredes-Vazquez JG; Martínez-Resendez MF; Fabiani MA
Vasc Endovascular Surg; 2022 Feb; 56(2):144-150. PubMed ID: 34666570
[TBL] [Abstract][Full Text] [Related]
17. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
[TBL] [Abstract][Full Text] [Related]
18. CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.
Lee AY; Bauersachs R; Janas MS; Jarner MF; Kamphuisen PW; Meyer G; Khorana AA;
BMC Cancer; 2013 Jun; 13():284. PubMed ID: 23764005
[TBL] [Abstract][Full Text] [Related]
19. Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study.
Aljuhani O; Al Sulaiman K; Hafiz A; Eljaaly K; Alharbi A; Algarni R; Al Homaid S; Kahtani K; Alsulaiman T; Vishwakarma R; Al Ghamdi G; Alalawi M; Korayem GB
Saudi Pharm J; 2022 Apr; 30(4):398-406. PubMed ID: 35136364
[TBL] [Abstract][Full Text] [Related]
20. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.
Al-Samkari H; Gupta S; Leaf RK; Wang W; Rosovsky RP; Brenner SK; Hayek SS; Berlin H; Kapoor R; Shaefi S; Melamed ML; Sutherland A; Radbel J; Green A; Garibaldi BT; Srivastava A; Leonberg-Yoo A; Shehata AM; Flythe JE; Rashidi A; Goyal N; Chan L; Mathews KS; Hedayati SS; Dy R; Toth-Manikowski SM; Zhang J; Mallappallil M; Redfern RE; Bansal AD; Short SAP; Vangel MG; Admon AJ; Semler MW; Bauer KA; Hernán MA; Leaf DE;
Ann Intern Med; 2021 May; 174(5):622-632. PubMed ID: 33493012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
